|
1
|
Fire A, Xu S, Montgomery MK, Kostas SA,
Driver SE and Mello CC: Potent and specific genetic interference by
double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hannon GJ: RNA interference. Nature.
418:244–251. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Rådmark O, Kim S and Kim VN: The nuclear RNase
III Drosha initiates microRNA processing. Nature. 425:415–419.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bernstein E, Caudy AA, Hammond SM and
Hannon GJ: Role for a bidentate ribonuclease in the initiation step
of RNA interference. Nature. 409:363–366. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sevignani C, Calin GA, Siracusa LD and
Croce CM: Mammalian microRNAs: A small world for fine-tuning gene
expression. Mamm Genome. 17:189–202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McManus MT and Sharp PA: Gene silencing in
mammals by small interfering RNAs. Nat Rev Genet. 3:737–747. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meister G, Landthaler M, Patkaniowska A,
Dorsett Y, Teng G and Tuschl T: Human Argonaute2 mediates RNA
cleavage targeted by miRNAs and siRNAs. Mol Cell. 15:185–197. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Halder J, Kamat AA, Landen CN Jr, Han LY,
Lutgendorf SK, Lin YG, Merritt WM, Jennings NB, Chavez-Reyes A,
Coleman RL, et al: Focal adhesion kinase targeting using in vivo
short interfering RNA delivery in neutral liposomes for ovarian
carcinoma therapy. Clin Cancer Res. 12:4916–4924. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Landen CN Jr, Chavez-Reyes A, Bucana C,
Schmandt R, Deavers MT, Lopez-Berestein G and Sood AK: Therapeutic
EphA2 gene targeting in vivo using neutral liposomal small
interfering RNA delivery. Cancer Res. 65:6910–6918. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McInnes IB and Schett G: The pathogenesis
of rheumatoid arthritis. N Engl J Med. 365:2205–2219. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang RY, Huang QC and Burgering BM: Novel
insight into the role of α-actinin-1 in rheumatoid arthritis.
Discov Med. 17:75–80. 2014.PubMed/NCBI
|
|
12
|
Salemi S, Biondo MI, Fiorentino C, Argento
G, Paolantonio M, Di Murro C, Malagnino VA, Canzoni M, Diamanti AP
and D'Amelio R: Could early rheumatoid arthritis resolve after
periodontitis treatment only? Case report and review of the
literature. Medicine (Baltimore). 93:e1952014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ursini F, Russo E, Hribal M Letizia, Mauro
D, Savarino F, Bruno C, Tripolino C, Rubino M, Naty S and Grembiale
RD: Abatacept improves whole-body insulin sensitivity in rheumatoid
arthritis: An observational study. Medicine (Baltimore).
94:e8882015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miao CG, Yang YY, He X, Xu T, Huang C,
Huang Y, Zhang L, Lv XW, Jin Y and Li J: New advances of microRNAs
in the pathogenesis of rheumatoid arthritis, with a focus on the
crosstalk between DNA methylation and the microRNA machinery. Cell
Signal. 25:1118–1125. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu T, Huang C, Chen Z and Li J:
MicroRNA-323-3p: A new biomarker and potential therapeutic target
for rheumatoid arthritis. Rheumatol Int. 34:721–722. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murata K, Furu M, Yoshitomi H, Ishikawa M,
Shibuya H, Hashimoto M, Imura Y, Fujii T, Ito H, Mimori T and
Matsuda S: Comprehensive microRNA analysis identifies miR-24 and
miR-125a-5p as plasma biomarkers for rheumatoid arthritis. PLoS
One. 8:e691182013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abou-Zeid A, Saad M and Soliman E:
MicroRNA 146a expression in rheumatoid arthritis: Association with
tumor necrosis factor-alpha and disease activity. Genet Test Mol
Biomarkers. 15:807–812. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Philippe L, Alsaleh G, Suffert G, Meyer A,
Georgel P, Sibilia J, Wachsmann D and Pfeffer S: TLR2 expression is
regulated by microRNA miR-19 in rheumatoid fibroblast-like
synoviocytes. J Immunol. 188:454–461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nagata Y, Nakasa T, Mochizuki Y, Ishikawa
M, Miyaki S, Shibuya H, Yamasaki K, Adachi N, Asahara H and Ochi M:
Induction of apoptosis in the synovium of mice with
autoantibody-mediated arthritis by the intraarticular injection of
double-stranded MicroRNA-15a. Arthritis Rheum. 60:2677–2683. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakasa T, Nagata Y, Yamasaki K and Ochi M:
A mini-review: MicroRNA in arthritis. Physiol Genomics. 43:566–570.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feldmann M: Translating molecular insights
in autoimmunity into effective therapy. Annu Rev Immunol. 27:1–27.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tokumaru S, Suzuki M, Yamada H, Nagino M
and Takahashi T: let-7 regulates Dicer expression and constitutes a
negative feedback loop. Carcinogenesis. 29:2073–2077. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin WJ and Yeh WC: Implication of
Toll-like receptor and tumor necrosis factor alpha signaling in
septic shock. Shock. 24:206–209. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Waterhouse PM, Wang MB and Lough T: Gene
silencing as an adaptive defence against viruses. Nature.
411:834–842. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meister G and Tuschl T: Mechanisms of gene
silencing by double-stranded RNA. Nature. 431:343–349. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Triboulet R, Mari B, Lin YL, Chable-Bessia
C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P,
Baillat V, et al: Suppression of microRNA-silencing pathway by
HIV-1 during virus replication. Science. 315:1579–1582. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matskevich AA and Moelling K: Dicer is
involved in protection against influenza A virus infection. J Gen
Virol. 88:2627–2635. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kobayashi T, Lu J, Cobb BS, Rodda SJ,
McMahon AP, Schipani E, Merkenschlager M and Kronenberg HM:
Dicer-dependent pathways regulate chondrocyte proliferation and
differentiation. Proc Natl Acad Sci USA. 105:1949–1954. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mizoguchi F, Izu Y, Hayata T, Hemmi H,
Nakashima K, Nakamura T, Kato S, Miyasaka N, Ezura Y and Noda M:
Osteoclast-specific Dicer gene deficiency suppresses osteoclastic
bone resorption. J Cell Biochem. 109:866–575. 2010.PubMed/NCBI
|
|
31
|
Jakymiw A, Ikeda K, Fritzler MJ, Reeves
WH, Satoh M and Chan EK: Autoimmune targeting of key components of
RNA interference. Arthritis Res Ther. 8:R872006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen G and Goeddel DV: TNF-R1 signaling: A
beautiful pathway. Science. 296:1634–1655. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guan Y, Yao H, Wang J, Sun K, Cao L and
Wang Y: NF-κB-DICER-miRs axis regulates TNF-α expression in
responses to endotoxin stress. Int J Biol Sci. 11:1257–1268. 2015.
View Article : Google Scholar : PubMed/NCBI
|
